Ettinger D A, Lasser M L
Honigman Miller Schwartz and Cohn, Detroit, MI, USA.
Healthc Financ Manage. 1997 Feb;51(2):27-9.
The Federal Trade Commission and the Department of Justice have modified their views on what constitutes price fixing by integrated delivery systems. Recently released enforcement policy statements indicate that joint agreements on price between competing providers will not necessarily constitute price fixing, even without risk sharing, if the system is sufficiently integrated. The enforcement policy statements indicate that if integration arises from the combined efforts of previously competing providers, involves improvements in clinical efficiency or quality, and demonstrates no anticompetitive intent, it will be sufficient to withstand Federal scrutiny.
联邦贸易委员会和美国司法部已就综合医疗服务体系中构成价格操纵的行为改变了看法。最近发布的执法政策声明表明，相互竞争的供应商之间就价格达成的联合协议不一定构成价格操纵，即便没有风险分担，只要该体系整合程度足够高。执法政策声明指出，如果整合源于先前相互竞争的供应商的共同努力，涉及临床效率或质量的提高，且未表现出反竞争意图，那么就足以经受住联邦政府的审查。
